Correction
Rok vydání: | 2021 |
---|---|
Předmět: |
self-management
endoscopic colitis diagnosis breastfeeding vitamin D calprotectin antibiotics surgery stress colonoscopy adalimumab antibiotic vaccine chemoprevention adherence granuloma computerised tomography CT 5-ASA azathioprine tofacitinib ultrasound adult Ulcerative colitis UC CMV prednisolone cognitive behavioural therapy CBT clostridium difficile colectomy inflammatory bowel disease IBD fetus anti-drug antibodies nutrition classification mesalazine tuberculosis TB enema surveillance biomarker janus kinase inhibator faecal microbial transplant virtual clinic pregnancy Crohn’s disease CD guideline management probiotic stricture vedolizumab corticosteroid ileitis budesonide integrin perianal therapeutic drug monitoring multidisciplinary team MDT Guidelines mercaptopurine psychology ustekinumab smoking ciclosporin primary stress 5-aminosalicylate thiopurine fistula cancer telephone clinic sigmoidoscopy hydrocortisone cyclosporine care endoscopy cytomegalovirus pouch therapy anaemia shared care anti-TNF vaccination magnetic resonance MR methylprednisolone JAK psychotherapy monitoring adolescent fatigue suppository infliximab diet pouchitis |
Zdroj: | Gut |
ISSN: | 1468-3288 |
Popis: | Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn’s and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn’s disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn’s disease, including patients, their families and friends. |
Databáze: | OpenAIRE |
Externí odkaz: |